MaximeLambilliotte

Associate

Brussels + 32.2.645.14.89

Maxime Lambilliotte's practice focuses on antitrust and competition law, both at the European Union and national levels. He advises major international companies in their proceedings with the European Commission and national competition authorities.

Maxime's experience spans all fields of competition law, including merger control, anticompetitive agreements, abuse of dominance, and State aid. He works regularly on complex cross-border merger cases, guiding companies from premerger counseling through all steps of the notification process. Most recently, Maxime was a member of the team that represented Bombardier in the €7.5 billion sale of its rail business to Alstom and NVIDIA in its $6.9 billion acquisition of Mellanox.

In addition to his competition law practice, he frequently advises clients on other aspects of EU law such as internal market issues and regulatory matters, particularly in the electronic communications sector.

Experience

  • Fidagh’s sale of Mestdagh cleared by Belgian Competition AuthorityFollowing an in-depth review, Jones Day secured approval from the Belgian Competition Authority (BCA) for Belgian company Fidagh S.A.’s sale of Mestdagh (a 120-year-old Belgian retailer) to the French company Groupement Les Mousquetaires’ subsidiary Intermarché.
  • T-Mobile closes European Commission investigation into network sharing with commitmentsJones Day represented T-Mobile Czech Republic a.s. in an investigation launched by the European Commission in 2016 in relation to the mobile network sharing agreements concluded between T-Mobile and its competitor CETIN/O2, in the Czech Republic.
  • Bombardier sells transportation business to Alstom for €6.2 billionJones Day served as antitrust and French corporate counsel in the €6.2 billion sale of Bombardier Inc.'s transportation business to Alstom S.A.
  • Astellas transfers DIFICLIR in Europe, Middle East, Africa, and selected CIS to Swiss Tillotts Pharma AG for €109 millionJones Day advised Astellas Pharma Europe Ltd. on the sale of distribution rights to the product "DIFICLIR" in Europe, Middle East, Africa, and selected Commonwealth of Independent States (CIS) countries to Swiss Tillotts Pharma AG for €109 million.
  • Qisda completes public tender offer for 19% stake in Alpha NetworksJones Day advised Qisda Corporation (TSE: 2352) in its public tender offer (unsolicited) to purchase up to 103,071,688 common shares (or approximately 19% stake) of Alpha Networks Inc. (TSE: 3380) at NT$30 per share.
  • Materion acquires Optics Balzers, AG for $160 millionJones Day advised Materion Corporation, a global supplier of highly engineered advanced enabling materials, in its $160 million acquisition of Optics Balzers, AG, an industry leader in thin film optical coatings.
  • NVIDIA acquires Mellanox Technologies for approximately $7 billionJones Day advised NVIDIA Corporation in its acquisition of Mellanox Technologies, Ltd., an Israel-based leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage.